<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01213784</url>
  </required_header>
  <id_info>
    <org_study_id>M20090047</org_study_id>
    <nct_id>NCT01213784</nct_id>
  </id_info>
  <brief_title>Optimized Glycemic Control in Heart Failure Patients With DM2:&quot;Effect on Left Ventricular Function and Skeletal Muscle&quot;</brief_title>
  <acronym>HFDM</acronym>
  <official_title>Optimized Glycemic Control in Type 2 Diabetics With Heart Failure:&quot;Effect on Left Ventricular Function and Skeletal Muscle&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Danish Diabetes Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators wish to investigate wether a more strict diabetic control improves cardiac
      function, muscle strength, exercise capacity and decreases symptoms.

      The investigators hypothesis is that improving the glycemic control in suboptimized diabetics
      with heart failure will improve cardiac performance, muscle strength, exercise capacity and
      decrease symptoms.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular function</measure>
    <time_frame>4 month</time_frame>
    <description>Left ventricular function will be evaluated using echocardiografi measuring:
- 2D Ejection fraction (using an ultrasound agent), global and regional tissue velocity, Strain / strain rate - all measures done during rest and dobutamin stress test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hormonal and metabolic profile</measure>
    <time_frame>4 month</time_frame>
    <description>bloodsamples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-minutes hall walk test</measure>
    <time_frame>4 month</time_frame>
    <description>using a hall walk protocol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise capacity and peak oxygen consumption</measure>
    <time_frame>4 month</time_frame>
    <description>using a treadmill test and continues oxygen consumption measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle strength and mass</measure>
    <time_frame>4 month</time_frame>
    <description>muscle strength: hand grip test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Type 2 Diabetes</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>optimized diabetic control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>each participant will be assigned to be optimized in a dedicated diabetic clinic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>participants will be assigned to follow what ever control they were in before the study and not to change any antidiabetic treatment during the interventions period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>all antidiabetic drugs will be appliable</intervention_name>
    <description>We expect all participants to be set on insulin during the intervention, however all types of insulin and other antidiabetics can be used goal: Hba1c lower than 7,5%</description>
    <arm_group_label>optimized diabetic control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ejection fraction =&lt;45%

          -  Diabetes

          -  Hba1c =&gt;7,5%

          -  In anticongestive treatment

          -  NYHA class 2-4

        Exclusion Criteria:

          -  Severe angina (CCS 3-4)

          -  Hemodynamic significant heart valve disease

          -  Congenital heart disease

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roni R Nielsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of cardiology, University hospital Aarhus Skejby</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. of cardiology, Aarhus university hospital Skejby</name>
      <address>
        <city>Aarhus</city>
        <state>Region Midtjylland</state>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 24, 2010</study_first_submitted>
  <study_first_submitted_qc>October 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2010</study_first_posted>
  <last_update_submitted>March 5, 2015</last_update_submitted>
  <last_update_submitted_qc>March 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoglycemic Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

